All In Biotech

Free tool

FAERS Monitor: Kisunla

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761248 or its brand name (Kisunla, Donanemab-Azbt). Reports on generic versions are filed under their own applications.

Reports

3,074

Serious

1,485

48% of reports

Hospitalization

382

Death reported

71

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • amyloid related imaging abnormality-oedema/effusion503
  • amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits416
  • infusion related reaction390
  • headache276
  • flushing196
  • amyloid related imaging abnormalities181
  • nausea140
  • cerebral haemorrhage130
  • dizziness129
  • cerebral microhaemorrhage109
  • chills105
  • dyspnoea105
  • confusional state93
  • back pain83
  • fall79

Reports by year received

View as table
YearReports
202474
20251,440
20261,560

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,085 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
amyloid related imaging abnormalitiesSignal1819047.57267.2701,468
amyloid related imaging abnormality-oedema/effusionSignal5034738.14252.91,405,333
amyloid related imaging abnormality-microhaemorrhages and haemosiderin depositsSignal4164336.13855.01,101,373
cerebral microhaemorrhageSignal1092163.61749.5177,411
infusion related reactionSignal39040.536.914,940
cerebral haemorrhageSignal13024.921.12,957
flushingSignal19613.211.52,207
chillsSignal1056.15.1448
confusional stateSignal933.93.2203
headacheSignal2763.02.7380
back painSignal832.42.070
dizziness1291.81.543
fall791.61.319
dyspnoea1051.31.16
nausea1401.21.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.